DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Citigroup Maintains Buy on Epizyme, Raises Price Target to $35

Citigroup maintains Epizyme (NASDAQ:EPZM) with a Buy and raises the price target from $25 to $35.

Benzinga · 01/23/2020 13:01

Citigroup maintains Epizyme (NASDAQ:EPZM) with a Buy and raises the price target from $25 to $35.